Interleukin-6 as a therapy target in oral squamous carcinoma

By Culig Zoran  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

By Maes Michael   Anderson George   Kubera Marta   Berk Michael  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 495-512

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2095-2103

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3816-3827

Bentham Science Publishers

Access to resources Recommend Favorite

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 6, 2008-12 ,pp. : 512-523

Bentham Science Publishers

Access to resources Recommend Favorite